Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (3 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Type
(
1 selected
)
Type
Guidance (56)
Guidance programme
(
1 selected
)
Guidance programme
Clinical guidelines (23)
Diagnostics guidance (3)
Highly specialised technologies guidance (1)
Interventional procedures guidance (22)
Medical technologies guidance (2)
Medicines practice guidelines (3)
NICE guidelines (34)
Public health guidelines (7)
Social care guidelines (13)
Technology appraisal guidance (56)
Apply filters
Showing 21 to 30 of 56
Sort by
Date
Title
Apply sorting
Last updated date between 1/4/2016 and 30/4/2017
Remove Last updated date between 1/4/2016 and 30/4/2017 filter
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia
TA425
21 December 2016
21 December 2016
Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia
TA426
21 December 2016
21 December 2016
Ticagrelor for preventing atherothrombotic events after myocardial infarction
TA420
14 December 2016
14 December 2016
Dapagliflozin in combination therapy for treating type 2 diabetes
TA288
26 June 2013
23 November 2016
Nivolumab for previously treated advanced renal cell carcinoma
TA417
23 November 2016
23 November 2016
Dapagliflozin in triple therapy for treating type 2 diabetes
TA418
23 November 2016
23 November 2016
Apremilast for treating moderate to severe plaque psoriasis
TA419
23 November 2016
23 November 2016
Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor
TA415
26 October 2016
26 October 2016
Elbasvir–grazoprevir for treating chronic hepatitis C
TA413
26 October 2016
26 October 2016
Cobimetinib in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma
TA414
26 October 2016
26 October 2016
Previous page
1
2
Current page
3
4
5
6
Page
3
of
6
Next page
Results per page
10
25
50
All
Back to top